Theophylline Inhibits Capillary Degeneration in Early Diabetic Retinopathy
Investigative Ophthalmology & Visual Science · 2026
DOI: 10.1167/iovs.67.2.8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, 2026. Verfasst von Emma M Lessieur und 8 weiteren Autor:innen. Beteiligte Einrichtung: Brunson Center for Translational Vision Research, Gavin Herbert Eye Institute, University of California Irvine, Irvine, California, United States. Hauptthemen laut MEDLINE: Theophylline, Diabetic Retinopathy, Diabetes Mellitus, Experimental, Retinal Vessels. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NEI NIH HHS.
Abstract (Originalsprache)
Purpose
Recent evidence suggests that simultaneous inhibition of multiple diabetes-induced molecular abnormalities is a valuable approach toward inhibiting the development of early stages of diabetic retinopathy (DR). The methylxanthine, theophylline acts by multiple mechanisms in different diseases, and we investigated its effect on the development of lesions of early DR.
Methods
Wild-type C57Bl/6J male mice were made diabetic with streptozotocin at two to three months of age, and some were given theophylline or structurally related analogs for one to two months to assess effects on visual function and biochemical and physiological abnormalities in the retina, or for eight months to assess retinal vascular histopathology. Effects of theophylline on leukocytes were examined ex vivo, because leukocytes contribute to the retinal vascular pathology of diabetes.
Results
Retinal superoxide generation, expression of inflammatory proteins, leukocyte-mediated cytotoxicity against retinal endothelial cells, and degeneration of retinal capillaries were significantly increased in retinas of control diabetic mice, and theophylline inhibited each of these abnormalities. Of recognized actions of theophylline (adenosine receptor antagonist, antioxidant and anti-inflammatory agent, inducer of histone deacetylase activity, inhibitor of phosphodiesterases), the inhibition of phosphodiesterases, oxidative stress and inflammation seem most likely to account for the beneficial effects of the drug in DR. In contrast to the beneficial effect of theophylline on capillary degeneration, it did not inhibit the diabetes-induced dysfunction of the neural retina.
Conclusions
Theophylline significantly inhibited the degeneration of retinal capillaries in early DR and can help investigate mechanistic differences in the pathogenesis of retinal capillary degeneration and neural dysfunction in diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Brunson Center for Translational Vision Research, Gavin Herbert Eye Institute, University of California Irvine, Irvine, California, United States.
- Department of Ophthalmology, Case Western Reserve University, Cleveland, Ohio, United States.
Förderung
- NEI NIH HHS
Zitieren
APA
Lessieur, E. M., Saadane, A., Du, Y., Kiser, J., Oum, A., Bollinger, Z. R., Lee, C. A., Tang, J., & Kern, T. S. (2026). Theophylline Inhibits Capillary Degeneration in Early Diabetic Retinopathy. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.2.8
Vancouver
Lessieur EM, Saadane A, Du Y, Kiser J, Oum A, Bollinger ZR, et al. Theophylline Inhibits Capillary Degeneration in Early Diabetic Retinopathy. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.2.8
BibTeX
@article{Lessieur2026,
author = {Lessieur, Emma M and Saadane, Aicha and Du, Yunpeng and Kiser, Jianying and Oum, Alice and Bollinger, Zak R and Lee, Chieh A and Tang, Jie and Kern, Timothy S},
title = {Theophylline Inhibits Capillary Degeneration in Early Diabetic Retinopathy},
journal = {Investigative Ophthalmology & Visual Science},
year = {2026},
doi = {10.1167/iovs.67.2.8}
}
EUVIMED